tiprankstipranks
Trending News
More News >
PCI Biotech Holding ASA (DE:4QG)
FRANKFURT:4QG
Germany Market
Advertisement

PCI Biotech Holding ASA (4QG) Financial Statements

Compare
1 Followers

PCI Biotech Holding ASA Financial Overview

PCI Biotech Holding ASA's market cap is currently €4.68M. The company's EPS TTM is €; its P/E ratio is ―; PCI Biotech Holding ASA is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 6.74Mkr 2.99Mkr 0.00kr 0.00kr 0.00
Gross Profitkr 6.74Mkr 2.99Mkr -633.00Kkr -2.54Mkr -2.21M
Operating Incomekr -17.95Mkr -22.24Mkr -56.45Mkr -86.03Mkr -82.12M
EBITDAkr -17.65Mkr -22.22Mkr -54.10Mkr -82.70Mkr -69.63M
Net Incomekr -16.42Mkr -20.32Mkr -53.74Mkr -88.48Mkr -72.64M
Balance Sheet
Cash & Short-Term Investmentskr 27.07Mkr 41.18Mkr 55.97Mkr 115.18Mkr 187.17M
Total Assetskr 31.21Mkr 44.05Mkr 63.48Mkr 135.98Mkr 209.12M
Total Debtkr 336.00Kkr 319.00Kkr 770.00Kkr 1.91Mkr 673.00K
Net Debtkr -26.73Mkr -40.86Mkr -55.20Mkr -113.27Mkr -186.50M
Total Liabilitieskr 7.76Mkr 5.01Mkr 6.08Mkr 22.19Mkr 19.88M
Stockholders' Equitykr 23.45Mkr 39.04Mkr 57.40Mkr 113.79Mkr 189.24M
Cash Flow
Free Cash Flowkr -13.76Mkr -14.97Mkr -59.04Mkr -68.65Mkr -81.31M
Operating Cash Flowkr -13.76Mkr -14.97Mkr -59.04Mkr -68.31Mkr -77.39M
Investing Cash Flowkr 0.00kr 0.00kr 0.00kr -341.00Kkr -3.92M
Financing Cash Flowkr -357.00Kkr -442.00Kkr -678.00Kkr -673.00Kkr -352.00K
Currency in NOK

PCI Biotech Holding ASA Earnings and Revenue History

PCI Biotech Holding ASA Debt to Assets

PCI Biotech Holding ASA Cash Flow

PCI Biotech Holding ASA Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis